Also trades as: 4587.T (JPX) · $vol 7M

$7.29

+0.00 (+0.00%)

OTC · Healthcare · Biotechnology · Tech Score Buy · Power 60 · $936.7M mcap · 91M float · 0.0002% daily turnover · Short 90% of daily vol

Revenue

$18.5B -60.3% ▼

5Y CAGR: +20.8%

Gross Profit

$7.5B -78.2% ▼

5Y CAGR: +6.2%

Operating Income

-$5.0B -123.6% ▼

Net Income

-$3.8B -125.0% ▼

EPS (Diluted)

$-29.80 -125.8% ▼

EBITDA

-$2.9B -112.0% ▼

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2024	FY2025
Revenue	$11.7B	$9.4B	$26.9B	$46.7B	$18.5B
YoY Growth	+61.8%	-19.8%	+186.7%	+0.0%	-60.3%
Cost of Revenue	$2.1B	$2.4B	$8.7B	$12.2B	$11.0B
Gross Profit	$9.5B	$7.0B	$18.1B	$34.5B	$7.5B
Gross Margin	81.6%	74.8%	67.5%	73.9%	40.6%
R&D Expenses	$0	$0	$2.9B	$4.0B	$5.0B
SG&A Expenses	$0	$0	$6.2B	$8.6B	$7.5B
Operating Expenses	$2.5B	$2.6B	$9.1B	$13.4B	$12.5B
Operating Income	$7.0B	$4.4B	$9.0B	$21.1B	-$5.0B
Operating Margin	59.9%	47.2%	33.4%	45.2%	-26.9%
Interest Expense	$0	$0	$2.3B	$659M	$501M
Income Before Tax	$6.0B	$4.8B	$6.7B	$20.9B	-$5.3B
Tax Expense	$1.6B	$1.2B	-$901M	$5.9B	-$1.6B
Net Income	$4.4B	$3.6B	$7.6B	$15.0B	-$3.8B
Net Margin	38.1%	38.5%	28.1%	32.2%	-20.2%
EPS (Diluted)	$34.26	$19.81	$58.14	$115.68	$-29.80
EBITDA	$8.5B	$5.0B	$10.9B	$23.8B	-$2.9B
Shares Outstanding	130M	130M	130M	130M	129M

Line Item	FY2023 Q2	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$4.5B	$32M	$4.2B	$4.3B	$4.4B	$5.7B	$4.8B	$4.4B
Cost of Revenue	$2.7B	$3.1B	$18M	$18M	$2.7B	$3.0B	$2.8B	$2.5B
Gross Profit	$1.8B	$2.0B	$10M	$12M	$1.7B	$2.7B	$2.0B	$1.9B
Gross Margin	40.6%	6087.4%	0.2%	0.3%	38.7%	47.4%	42.6%	43.5%
R&D Expenses	$798M	$11M	$7M	$8M	$1.2B	$1.7B	$1.2B	$1.4B
SG&A Expenses	$1.7B	$22M	$12M	$13M	$2.0B	$1.9B	$1.9B	$1.9B
Operating Expenses	$2.5B	$33M	$19M	$21M	$3.1B	$3.6B	$3.2B	$3.3B
Operating Income	-$720M	-$20M	-$9M	-$9M	-$1.4B	-$926M	-$1.1B	-$1.4B
Operating Margin	-16.1%	-62.5%	-0.2%	-0.2%	-33.1%	-16.3%	-23.8%	-30.9%
Interest Expense	$20M	$1M	$1M	$1M	$76M	$58M	$156M	$103M
Income Before Tax	-$711M	-$22M	-$10M	-$10M	-$1.5B	-$973M	-$1.2B	-$1.4B
Tax Expense	-$231M	-$5M	-$3M	-$2M	-$388M	-$441M	-$349M	-$311M
Net Income	-$480M	-$17M	-$7M	-$8M	-$1.1B	-$532M	-$860M	-$1.1B
Net Margin	-10.8%	-51.4%	-0.2%	-0.2%	-25.4%	-9.4%	-17.9%	-25.7%
EPS (Diluted)	$-3.70	$-0.13	$-0.05	$-0.06	$-8.60	$-4.13	$-6.66	$-8.83
EBITDA	-$79M	-$2.9B	-$4M	-$5M	-$876M	-$392M	-$594M	-$917M
Shares Outstanding	130M	130M	130M	129M	129M	129M	129M	129M

PPTDF OTC